StonvexLoading…
StonvexCore line items from KEYS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-01-31 | Q3 2025 2025-07-31 | Q1 2025 2025-01-31 | Q3 2024 2024-07-31 |
|---|---|---|---|---|
Revenue | $1.60B | $3.96B | $1.30B | $3.69B |
Operating Income | $248.00M | $659.00M | $218.00M | $603.00M |
Net Income | $281.00M | $617.00M | $169.00M | $687.00M |
EPS (Diluted) | $1.63 | $3.56 | $0.97 | $3.92 |
Total Assets | $11.48B | $10.65B | $9.39B | $9.32B |
Total Liabilities | $5.28B | $4.98B | $4.20B | $4.09B |
Cash & Equivalents | $2.18B | $2.64B | $2.06B | $1.63B |
Free Cash Flow OCF − CapEx | $407.00M | $1.09B | $346.00M | $577.00M |
Shares Outstanding | 173.00M | 173.00M | 174.00M | 175.00M |